MA53897A - Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant - Google Patents
Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenantInfo
- Publication number
- MA53897A MA53897A MA053897A MA53897A MA53897A MA 53897 A MA53897 A MA 53897A MA 053897 A MA053897 A MA 053897A MA 53897 A MA53897 A MA 53897A MA 53897 A MA53897 A MA 53897A
- Authority
- MA
- Morocco
- Prior art keywords
- piperazinyl
- ethoxy
- synthesis
- production
- application
- Prior art date
Links
- -1 PIPERAZINYL-ETHOXY-BROMOPHENYL Chemical class 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18306354 | 2018-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA53897A true MA53897A (fr) | 2022-01-19 |
Family
ID=63965576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA053897A MA53897A (fr) | 2018-10-15 | 2019-10-14 | Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant |
Country Status (14)
Country | Link |
---|---|
US (1) | US11512062B2 (fr) |
EP (1) | EP3867233A1 (fr) |
JP (1) | JP7448532B2 (fr) |
KR (1) | KR20210076094A (fr) |
CN (1) | CN112930340A (fr) |
AR (1) | AR116635A1 (fr) |
BR (1) | BR112021006467A2 (fr) |
CA (1) | CA3115608A1 (fr) |
EA (1) | EA202190989A1 (fr) |
IL (1) | IL282094A (fr) |
MA (1) | MA53897A (fr) |
MX (1) | MX2021004288A (fr) |
NZ (1) | NZ774813A (fr) |
WO (1) | WO2020078875A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202315637A (zh) | 2021-06-11 | 2023-04-16 | 美商基利科學股份有限公司 | Mcl-1抑制劑與抗癌劑之組合 |
TW202317200A (zh) | 2021-06-11 | 2023-05-01 | 美商基利科學股份有限公司 | Mcl-1抑制劑與抗體藥物接合物之組合 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401824A (en) * | 1982-03-08 | 1983-08-30 | The Upjohn Company | Benzopyran compounds, derivatives of prostaglandins |
US6867203B2 (en) * | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
GB0500029D0 (en) * | 2005-01-04 | 2005-02-09 | Univ Belfast | Basic ionic liquids |
US7759337B2 (en) * | 2005-03-03 | 2010-07-20 | Amgen Inc. | Phthalazine compounds and methods of use |
WO2007047146A2 (fr) * | 2005-10-11 | 2007-04-26 | Intermune, Inc. | Inhibiteurs de réplication virale |
TW201107302A (en) * | 2009-06-26 | 2011-03-01 | Glaxo Group Ltd | Compounds |
BR112012011310A2 (pt) * | 2009-11-11 | 2016-04-12 | Dainippon Sumitomo Pharma Co | compostos derivados de 8-azabiciclo[3.2.1]octano-8-carboxamida, seu medicamento, seu agente terapêutico e seu uso |
EP3444252B1 (fr) * | 2011-06-17 | 2019-08-14 | NantEnergy, Inc. | Cellule electrochimique comprenant un additif hetero-ionique |
TWI464242B (zh) * | 2012-10-26 | 2014-12-11 | Ind Tech Res Inst | 負介電異方性液晶化合物、液晶顯示器、與光電裝置 |
KR102006994B1 (ko) * | 2013-03-28 | 2019-08-02 | 주식회사 삼양사 | 신규 페난트렌 화합물, 이의 제조방법 및 이를 이용한 유기전자소자 |
WO2015024203A1 (fr) * | 2013-08-20 | 2015-02-26 | Leo Pharma A/S | Nouveaux composés ii antagonistes du récepteur de la neurokinine 1 |
FR3015483B1 (fr) * | 2013-12-23 | 2016-01-01 | Servier Lab | Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CA2946471C (fr) * | 2014-04-25 | 2018-08-07 | Pfizer Inc. | Composes heteroaromatiques bicyclique fusionnes et leur utilisation comme ligands de dopamine d1 |
WO2015187089A1 (fr) * | 2014-06-04 | 2015-12-10 | Thomas Helledays Stiftelse För Medicinsk Forskning | Inhibiteurs de mth1 destinés au traitement des états inflammatoires et auto-immuns |
FR3037959B1 (fr) | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3037958B1 (fr) | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3046792B1 (fr) | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US10106553B2 (en) * | 2016-04-11 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
KR101891263B1 (ko) * | 2016-07-20 | 2018-08-23 | 주식회사 엘지화학 | 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자 |
LT3532067T (lt) * | 2016-10-28 | 2022-08-25 | Les Laboratoires Servier | Liposominė vaisto forma, skirta naudoti gydant vėžį |
CN107573360B (zh) * | 2017-10-27 | 2019-08-09 | 都创(上海)医药科技有限公司 | 一种多靶点小分子化合物s63845的制备方法 |
-
2019
- 2019-10-11 AR ARP190102897A patent/AR116635A1/es unknown
- 2019-10-14 JP JP2021520367A patent/JP7448532B2/ja active Active
- 2019-10-14 EA EA202190989A patent/EA202190989A1/ru unknown
- 2019-10-14 MA MA053897A patent/MA53897A/fr unknown
- 2019-10-14 NZ NZ774813A patent/NZ774813A/en unknown
- 2019-10-14 CA CA3115608A patent/CA3115608A1/fr active Pending
- 2019-10-14 WO PCT/EP2019/077729 patent/WO2020078875A1/fr unknown
- 2019-10-14 EP EP19784071.3A patent/EP3867233A1/fr active Pending
- 2019-10-14 KR KR1020217014515A patent/KR20210076094A/ko not_active Application Discontinuation
- 2019-10-14 MX MX2021004288A patent/MX2021004288A/es unknown
- 2019-10-14 US US17/283,107 patent/US11512062B2/en active Active
- 2019-10-14 CN CN201980067808.2A patent/CN112930340A/zh active Pending
- 2019-10-14 BR BR112021006467-2A patent/BR112021006467A2/pt unknown
-
2021
- 2021-04-06 IL IL282094A patent/IL282094A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2019362310A1 (en) | 2021-05-13 |
US20210380549A1 (en) | 2021-12-09 |
EP3867233A1 (fr) | 2021-08-25 |
US11512062B2 (en) | 2022-11-29 |
WO2020078875A1 (fr) | 2020-04-23 |
CA3115608A1 (fr) | 2020-04-23 |
EA202190989A1 (ru) | 2021-07-05 |
KR20210076094A (ko) | 2021-06-23 |
CN112930340A (zh) | 2021-06-08 |
NZ774813A (en) | 2024-07-26 |
BR112021006467A2 (pt) | 2021-07-13 |
AR116635A1 (es) | 2021-05-26 |
MX2021004288A (es) | 2021-05-31 |
JP7448532B2 (ja) | 2024-03-12 |
JP2022512694A (ja) | 2022-02-07 |
IL282094A (en) | 2021-05-31 |
TW202033506A (zh) | 2020-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42231A (fr) | Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant | |
DK3728215T3 (da) | One-pot-proces til fremstilling af racemisk nikotin ved omsætning af ethylnicotinat med N-vinylpyrrolidon i nærvær af natriumethanolat eller kaliumethanolat eller blandinger deraf | |
MA52665A (fr) | Procédé d'amélioration de l'expression de l'hémoglobine foetale | |
MA46744A (fr) | Composés mono et spirocycliques contenant du cyclobutane et de l'azétidine en tant qu'inhibiteurs de l'intégrine alpha v | |
MA50855A (fr) | Procédé de génération de compositions thérapeutiques de cellules modifiées | |
MA51988A (fr) | Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale | |
MA53897A (fr) | Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant | |
MA51114A (fr) | Procédé de production d'une compositions de lymphocytes t modifiés | |
FR3037957B1 (fr) | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
MA41861A (fr) | Composition d'élastomère thermoplastique et son procédé de production | |
MA47000A (fr) | Procédé et composition pour l'obtention d'un produit de farine amélioré | |
MA48723A (fr) | Procédé de production d'anticorps multispécifiques | |
MA42232B1 (fr) | Nouveaux dérivés d'acide aminé, leur procédé de préparation et compositions pharmaceutiques les contenant | |
CO6531444A2 (es) | Métodos sintéticos para compuestos espiro-oxoindol | |
MA38803A1 (fr) | Nouveaux dérivés d'indolizine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
IL275321A (en) | Treatment of diseases associated with the expression of DUX4 | |
MA55917A (fr) | Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie | |
MA56056A (fr) | Nouveau procédé efficace de synthèse de 2-amino-5-chloro-n-,3-diméthylbenzamide | |
MA49700A (fr) | Procédé amélioré pour la préparation de dérivés d'aminopyrimidine | |
MA53728A (fr) | Nouveau procédé enzymatique pour la production de produits de houblon modifiés | |
BR112016013618A8 (pt) | derivados de maleimida como moduladores de série de reação de wnt, seus usos, composição farmacêutica e processo para a preparação dos mesmos | |
MA53900A (fr) | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant | |
CY1122172T1 (el) | Τροποποιητες θειαζολης των a3 υποδοχεων αδενοσινης | |
MA51870A (fr) | Procédé pour la préparation de composés coupleurs de médicaments | |
MA47409A (fr) | Nouveau procédé de synthèse de 1-aryl-1-trifluorométhylcyclopropanes |